What is Listing Gains in an IPO?

Few things in retail investing generate as much excitement as the listing day of an IPO. Fortunes appear to be made and lost within the first hour of trading. Social media fills with screenshots of green portfolios and the occasional cry of disappointment. The term listing gain is thrown around constantly, as though it is the only outcome that matters. But listing gains are one of the most misunderstood concepts in IPO investing. They are real. They can be significant.

And in 2025, they reminded an entire generation of retail investors just how quickly the winds can shift. This article explains what listing gains are, how they are calculated, what drives them, and why chasing them without context is one of the costliest mistakes a retail investor can make.

A listing gain is the percentage increase in a stock’s price from its IPO issue price to its opening price on the day it begins trading on the stock exchange. It is the profit available to an investor who was allotted shares in the IPO and chooses to sell them the moment trading begins.

How Listing Gain Is Calculated

IPO Issue Price: ₹200 per share

Listing Price on Day 1: ₹260 per share

Listing Gain = (Listing Price – Issue Price) ÷ Issue Price × 100

                     = (260 – 200) ÷ 200 × 100

                     = 30%

An investor allotted 1 lot of 65 shares would gain:

65 shares × ₹60 per share = ₹3,900 on a ₹13,000 investment in a single day.

The opposite scenario, where the listing price falls below the issue price, is called a listing loss or a discount listing. This happens more often than many retail investors expect, and 2025 served as a sharp reminder of that reality.

“A listing gain is the reward for being right about an IPO. A listing loss is the market’s first verdict on the price the company asked for.”

 

Listing gains are not stable. They swing sharply with market conditions, valuations, and investor sentiment. Looking at three consecutive years tells a clear and cautionary story.

Year	Avg First Day Gain	Median Listing Gain
2023	~27%	16.5%
2024	~29%	15.2%
2025	~8.4%	3.8%

The headline numbers from 2025 are striking. Of 108 mainboard IPOs, 65 percent listed at a profit on Day 1. That sounds reassuring. But the full picture is more sobering: by the end of 2025, 59 percent of those same IPOs were trading below their listing price. Investors who held shares after listing day had given back their initial gains and more. The market rewarded the exits, not the holders.

3.8% Median listing gain in 2025, down from 15.2% in 2024

65% Of 2025 IPOs listed at a gain on Day 1

59% Of 2025 IPOs trading below their listing price by year end

The median listing gain of 3.8 percent in 2025 is particularly telling. The median is the middle value, not the average pulled upward by a few spectacular performers. It means that half of all IPOs listed at less than 3.8 percent gain. After brokerage fees and the opportunity cost of blocked capital during the subscription period, many investors who sold on listing day were left with returns that barely justified the effort.

The listing price is not set by anyone. It is discovered by the market in real time as buy and sell orders collide in the first minutes of trading. Several forces shape where that price lands.

Factor	How It Influences Listing Price	Reliability as a Predictor
Subscription levels	Heavy oversubscription signals strong demand and typically supports a higher listing	High. Especially QIB subscription above 50 times
Valuation vs listed peers	IPOs priced below comparable listed companies tend to list at a premium	High. The most durable signal of all
Market conditions on Day 1	A falling Nifty or Sensex on listing day can drag down even well priced IPOs	Moderate. External and unpredictable
Anchor investor quality	Strong anchor allocation from marquee institutions signals institutional confidence	Moderate. Quality matters more than quantity
Grey market premium (GMP)	Informal pre listing trading signal. Reflects sentiment but is unregulated and unreliable	Low. Directionally useful but frequently wrong
Issue size	Smaller IPOs have historically averaged higher listing gains than mega issues	Moderate. KPMG FY25: small IPOs averaged 37% vs 29% for large ones

Before every IPO lists, a number circulates obsessively in investor circles: the Grey Market Premium or GMP. It is the price at which IPO shares are changing hands in the grey market, an informal and completely unregulated parallel trading channel that exists between allotment and listing.

The formula is simple. If an IPO has an upper price band of ₹200 and shares are trading in the grey market at ₹240, the GMP is ₹40 or 20 percent. Investors interpret this as an expectation that the stock will list at ₹240 or higher. That expectation is often correct in direction. But the magnitude is frequently wrong, and the direction itself has failed enough times to warrant serious caution.

GMP Concept	What It Means	Key Limitation
Grey Market Premium (GMP)	Premium over the issue price at which shares trade informally before listing	Unregulated, unaudited, and easily manipulated by operators
Kostak Rate	Fixed price paid for an entire IPO application before allotment is confirmed. Buyer pays regardless of whether allotment is received	Seller locks in a fixed gain but forfeits any upside if the stock surges
Subject to Sauda (STS)	A conditional grey market deal that applies only if the applicant receives an allotment. More common than Kostak	If the seller does not get allotment, the deal collapses and no money changes hands

Grey market transactions in India carry no legal enforceability and no regulatory protection. Promoters, operators, and large applicants have been known to inflate GMP to generate retail excitement before an IPO. Multiple IPOs with high GMP have listed at a discount and vice versa. Use GMP as one data point among many, never as a decision on its own.

The story of IPO listing gains in 2025 is best told through its extremes. The gap between the best and worst performers was wide enough to remind every investor that IPO investing is never a one-size outcome.

2025 Listing Day: The Range of Outcomes

Best performer: Stallion India Fluorochemicals surged 154% from its issue price, one of the highest listing gains of the year.

Mega issue, muted gain: Tata Capital, the largest IPO of 2025 at ₹15,000 crore, listed with a gain of just 1%. Scale offered no listing day advantage.

Strong debut, strong hold: Meesho listed at a gain and sustained post listing momentum, rewarding both those who sold on Day 1 and those who held.

Worst performer: Glottis Limited fell 35% on listing day and was trading approximately 45% below its issue price by year end.

SME segment: Of 254 SME listings till December 2025, around 120 debuted in positive territory while 132 ended in the red, a near even split.

The KPMG FY25 analysis added a useful insight about deal size: smaller IPOs below ₹200 crore averaged 37 percent listing gains, while larger ones above ₹5,000 crore averaged 29 percent. Size is not destiny on listing day, but smaller, tightly priced issues have historically offered more room for the market to rerate upward.

Here is the uncomfortable truth about listing gains that most IPO content avoids. A listing gain is only real if you sell. Investors who hold shares after listing day are no longer playing the IPO game. They are now equity investors in the company, subject to everything that drives stock prices over months and years: earnings, valuations, sector trends, management decisions, and macro conditions.

In 2025, 59 percent of IPOs were trading below their listing price by year end. That means a majority of investors who saw a green number on listing day and chose to hold gave back their gains. This is not unique to 2025. It is a recurring pattern in IPO markets globally. The listing pop often reflects subscription euphoria, not fundamental value.

Three Situations Where Listing Gains Disappear

The IPO was overvalued from the start. High subscription drove the listing price up, but the business could never justify it. As quarterly results arrive, the stock rerates downward.

Market conditions deteriorate post listing. Even a genuinely good business can see its stock fall if the broader market sells off in the weeks after its debut.

The lock in period ends and institutional sellers exit. Anchor investors and pre IPO shareholders face lock in periods of 30 to 90 days. When those expire, selling pressure often builds.

The most important distinction in IPO investing is between those who are playing for the listing gain and those who are investing in a business. Neither approach is wrong. But they require completely different frameworks.

Approach	Listing Gain Play	Long Term Investment
Primary goal	Sell on Day 1 or within a few days of listing	Hold shares for one year or more based on business quality
What matters most	Subscription levels, GMP, market sentiment, lot size	Business fundamentals, valuation, earnings growth, management
Risk	Listing at a discount wipes out the gain entirely	Post listing volatility can be weathered if thesis is intact
Capital deployed	Blocked briefly during subscription. Released if not allotted	Fully deployed for the duration of the holding period
Key metric to watch	QIB subscription and anchor investor quality	Price to earnings vs peers, revenue growth, profit margins

Most retail investors in India are implicitly playing for listing gains without admitting it to themselves. There is nothing wrong with that strategy. But it comes with a clear implication: the IPO price at which you apply is the most important number in the equation. If the valuation is stretched, no amount of hype can sustain the listing price for long. If the valuation is reasonable, you can afford to hold even if the listing is muted.

Rather than tracking GMP obsessively in the days before an IPO closes, spend that time on these four questions. They are more reliable predictors of listing outcome than any grey market number.

• What is the QIB subscription level? Institutional investors, who do the deepest due diligence, vote with their capital. A QIB subscription above 50 times is a strong signal. QIBs consistently out subscribing retail is the most meaningful demand indicator available.

• How is the IPO priced relative to listed peers? If a company is pricing its IPO at a significant premium to comparable businesses already trading on the exchange, the market will notice. Valuation discipline is the single strongest predictor of post listing performance.

• Who are the anchor investors? The list of anchor investors is published before the IPO opens. Reputable domestic mutual funds and foreign institutional investors anchoring an issue at a meaningful allocation signals confidence. Lesser known anchor names with no track record warrant closer scrutiny.

• What is the purpose of the funds raised? Fresh issue proceeds going toward genuine business expansion support a credible growth story. A large Offer for Sale component means existing shareholders are cashing out. That is not automatically bad, but it means the IPO will not bring fresh capital to grow the business.

Listing gains are real, sometimes spectacular, and always uncertain. They are the immediate market verdict on whether an IPO was priced right and timed well. In 2025, that verdict was more nuanced than in the two years before it. The era of easy, broad listing gains is behind us. What remains is a market that still rewards good companies at fair prices but punishes hype, stretched valuations, and blind subscriptions with far less mercy than before.